Rainbow Childrens Medicare · NSE: RAINBOW · BSE: 543524
Q2 FY25 results · Jul–Sep 2024
Rainbow Childrens Medicare reported revenue from operations of ₹417.46 crore (up 25.5% from Q2 FY24) and net profit of ₹79.00 crore (up 25.1% from Q2 FY24) for Q2 FY25 (Jul–Sep 2024), on a consolidated basis.
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 417.46 | 332.68 | +25.5% | 330.22 | +26.4% |
| Other income | 11.27 | 7.82 | +44.1% | 11.93 | −5.5% |
| Total income | 428.73 | 340.50 | +25.9% | 342.15 | +25.3% |
| Profit before tax | 105.35 | 85.25 | +23.6% | 53.35 | +97.5% |
| Net profit for the period | 79.00 | 63.16 | +25.1% | 39.73 | +98.9% |
| Attributable to shareholders of the company | 78.87 | 62.91 | +25.4% | 39.53 | +99.5% |
| EPS, basic (₹) | 7.77 | 6.20 | +25.3% | 3.89 | +99.7% |
| Net margin (%) | 18.9 | 19.0 | 12.0 |
| Item | Q2 FY25 | Q2 FY24 | YoY | Q1 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 403.93 | 318.67 | +26.8% | 315.02 | +28.2% |
| Other income | 10.72 | 8.88 | +20.8% | 11.48 | −6.6% |
| Total income | 414.65 | 327.54 | +26.6% | 326.50 | +27.0% |
| Profit before tax | 103.60 | 85.60 | +21.0% | 51.63 | +100.7% |
| Net profit for the period | 77.34 | 63.98 | +20.9% | 38.73 | +99.7% |
| EPS, basic (₹) | 7.62 | 6.30 | +21.0% | 3.82 | +99.5% |
| Net margin (%) | 19.1 | 20.1 | 12.3 |
Consolidated
- Filed with BSE
- 29 Oct 2024, 11:14 IST
- Board meeting
- 27 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 Oct 2024, 11:14 IST
- Board meeting
- 27 Oct 2024
- Period
- 01 Jul 2024 to 30 Sep 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE